See also this year's filing and all EDGAR filings for this company.
PDF Report 0001398733_2020_Aquestive_Therapeutics_Inc.pdf
Logs
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001398733, Aquestive Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 68,314,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 9,726,000 |
| 3 | remainder_Assets | 439,000 |
| 4 | LiabilitiesCurrent | 18,555,000 |
| 5 | LiabilitiesNoncurrent | 4,348,000 |
| 6 | remainder_Liabilities | 61,698,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 64,342,000 |
| 9 | ResearchAndDevelopmentExpense | 20,574,000 |
| 10 | remainder_Expenses | 29,679,000 |
| 11 | remainder_Revenues | 53,245,000 |
| 12 | remainder_NetIncome | -4,896,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 78,479,000 |
| 1 | Liabilities | 84,601,000 |
| 2 | Expenses | 114,595,000 |
| 3 | Revenues | 53,245,000 |
| 4 | StockholdersEquity | -6,122,000 |
| 5 | NetIncome | -66,246,000 |
| 6 | ComprehensiveNetIncome | -66,246,000 |
| 7 | BaseVar | 167,908,000 |
| 8 | EconomicCapitalRatio | -0.942 |